Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.
暂无分享,去创建一个
S. L. Silins | I. Misko | S. Elliott | S. Pye | C. Schmidt | S. Cross
[1] F. Mandelli,et al. Transcription of latent and replicative Epstein‐Barr‐virus genes in bone‐marrow and peripheral‐blood mononuclear cells of healthy donors , 1997 .
[2] Rekha Khanna,et al. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1. , 1996, Virology.
[3] S. Burrows,et al. Copyright � 1995, American Society for Microbiology Immune Regulation in Epstein-Barr Virus-Associated Diseases , 2022 .
[4] S. Modrow,et al. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus , 1995, Journal of virology.
[5] H. Stein,et al. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. , 1995, Blood.
[6] S. Burrows,et al. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Becker,et al. Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Perricaudet,et al. Detection of anti‐epstein‐barr‐virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma , 1991, International journal of cancer.
[9] J. Levy,et al. Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. , 1991, Clinical and experimental immunology.
[10] S. Burrows,et al. Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformants. , 1990, Cellular immunology.
[11] I. Ernberg,et al. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Epstein,et al. In vitro analysis of the epstein‐barr virus: Host balance in long‐term renal allograft recipients , 1985, International journal of cancer.
[13] M. Epstein,et al. A re‐examination of the epstein‐barr virus carrier state in healthy seropositive individuals , 1985, International journal of cancer.
[14] N. Raab-Traub,et al. Epstein-Barr virus replication in oropharyngeal epithelial cells. , 1984, The New England journal of medicine.